Member News
-
Valeo Pharma Provides Update on Private Payer Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler®
June 1, 2021 (Source) — Private payer health plan coverage in Canada for Enerzair Breezhaler and Atectura Breezhaler has reached…
-
Perimeter Medical Imaging AI Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 31, 2021 (Source) — Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology…
-
Hemostemix Announces that, Due to the COVID-19 Pandemic, the Annual and Special Meeting Will Only Be Held via Zoom and Shareholders are Requested to Follow the Meeting Instructions Mailed to the Shareholders of Record
May 31, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE:2VF0) (“Hemostemix” or the “Company”) reminds shareholders…
-
dynaCERT Announces Appointment of Stephen Kukucha to its Board of Directors
May 31, 2021 (Source) — dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”) is pleased…
-
Vital achieves formal acceptance of rare earth product from REEtec
2021-May-31-Vital-Achieves-Formal-Acceptance-of-Rare-Earth-Product.pdf
-
Hemostemix Announces the TSX Venture’s Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update
May 29, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO.F) (“Hemostemix” or the “Company”) is pleased…
-
Voyageur Pharmaceuticals Ltd. Announces Closing of Second Tranche of Private Placement
May 28, 2021 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) announces that, further to news releases…